Hagop Youssoufian
2012 - ZIOPHARM Oncology
In 2012, Hagop Youssoufian earned a total compensation of $1.3M as President of Research and Development and Chief Medical Officer at ZIOPHARM Oncology, a 31% decrease compared to previous year.
Compensation breakdown
| Bonus | $278,750 |
|---|---|
| Option Awards | $525,564 |
| Salary | $450,000 |
| Other | $52,545 |
| Total | $1,306,859 |
Youssoufian received $525.6K in option awards, accounting for 40% of the total pay in 2012.
Youssoufian also received $278.8K in bonus, $450K in salary and $52.5K in other compensation.
Rankings
In 2012, Hagop Youssoufian's compensation ranked 5,088th out of 11,487 executives tracked by ExecPay. In other words, Youssoufian earned more than 55.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,088 out of 11,487 | 56th |
Division Manufacturing | 1,778 out of 4,253 | 58th |
Major group Chemicals And Allied Products | 427 out of 1,203 | 65th |
Industry group Drugs | 278 out of 925 | 70th |
Industry Pharmaceutical Preparations | 219 out of 700 | 69th |
Source: SEC filing on April 30, 2014.
Youssoufian's colleagues
We found four more compensation records of executives who worked with Hagop Youssoufian at ZIOPHARM Oncology in 2012.